This Will be Eli Lilly’s Price in 2027 And Morgan Stanley Agrees

Quick Read

• LLY posted 48% gross maturation to $23 cardinal and EPS of $8.38, crushing the statement portion absorption lifted full-year guidance.

• Morgan Stanley raised its LLY people to $1,419 post-quarter, but Q2's 60% measurement maturation suggests expert statement targets inactive lag the cardinal story.

• Reaching $1,750 by August 2027 requires a 50% summation and hinges connected retatrutide's Q1 2027 BLA clearance and Zepbound sustaining its momentum.

• Act now: the expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks — and Eli Lilly didn't marque the cut. Grab the names FREE today.

Eli Lilly (NYSE:LLY) conscionable delivered 1 of the cleanest beat-and-raise quarters I person seen from a mega-cap pharma successful years. Revenue jumped 47.67% to $22.97 billion, EPS came successful astatine $8.38 versus the $6.5845 consensus, and absorption raised full-year gross guidance to $85 to $87 billion.

Shares are up 9.23% twelvemonth to date, good down the fundamentals. So tin Lilly scope $1,750 by August 2027? Let's tally the math.

Why Lilly Shares Are Stuck Despite a Blowout Quarter

The disconnect is real. Revenue maturation is moving adjacent 50%, but the banal is down 3.32% implicit the past week and 2.52% implicit the past month.

Two things are weighing connected sentiment. First, $2.78 cardinal successful Q2 IPR&D charges from 4 acquisitions muddied the reported net representation and pushed the effectual taxation complaint to 23.3%.

Second, realized prices fell astir 13%, with U.S. prices down astir 9% excluding rebates. Add a beta of conscionable 0.506, and you get a banal that grinds alternatively than sprints. Insiders person besides been nett sellers crossed 13 caller transactions. The fundamentals are intact. Just sound smothering a large net report.

Act now: the expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks — and Eli Lilly didn't marque the cut. Grab the names FREE today.

Wall Street Is Bullish, But Its Targets Look Late

The statement expert people sits astatine $1,276.96, with 5 Strong Buy, 17 Buy, 4 Hold, 1 Sell, and 1 Strong Sell ratings. That is 79% bullish. Post-quarter, Morgan Stanley raised its people to $1,419 from $1,347 with an Overweight rating, BMO's Evan Seigerman went to $1,400 from $1,300, and Wells Fargo's Mohit Bansal moved to $1,330 from $1,280.

Our ain basal lawsuit exemplary targets $1,430.26 for 22.26% upside, with a bull lawsuit astatine $1,639.16 and assurance astatine 90%. My view: analysts are anchored to pricing unit and missing volume. Q2 measurement grew 60%. That is the story.

The Path to $1,750 Per Share

Reaching $1,750 from today's terms of $1,169.86 would necessitate a summation of 49.6%. With guardant EPS of $38.14, a terms of $1,750 implies a guardant P/E of 46x. Our basal lawsuit of $1,430.26 already implies 37x, meaning the bold people requires astir 8.7x of further aggregate expansion. Achievable? Earnings are compounding accelerated capable to compress that aggregate naturally.